Volume 77, Issue 6_Suppl
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Until recent years, public interest and political investment in malaria prevention, control, and research have been stagnant. The global malaria agenda is now experiencing an unprecedented time of public and political will and momentum. At the heart of this favorable period lies a nascent, but increasingly sophisticated, global advocacy effort that has contributed to new and expanded malaria funding, programs, and technology. This paper reviews the elements of malaria’s rise to political and public prominence, tracks the increase in funding and policy commitments to malaria over the past decade, and comments on an evolving policymaking progress, increasing transparency and accountability in program governance, and the impact of philanthropic investments in malaria advocacy. In addition, the principles of sound advocacy are described along with the mechanisms that will underlie sustained pro-political momentum for malaria research, resources, and results.

“Today, we have begun to write the final chapter in the history of malaria. We have raised hopes and expectations of our people—we must not let them down. We cannot afford to let them down.”

—His Excellency Olusegan Obasanjo, President of Nigeria, Abuja Summit 2000


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Williams LL Jr., 1963. Malaria eradication in the United States. Am J Publ Health Nations Health 53 : 19–21.
    [Google Scholar]
  2. World Health Organization, 1973. Malaria eradication and other antimalarial activities in 1972. WHO Chron 27 : 516–524.
    [Google Scholar]
  3. World Health Organization Scientific Group on Parasitology of Malaria, 1969. Parasitology of Malaria: Report of a WHO Scientific Group. Geneva: World Health Organization, Technical Report Series.
  4. World Health Organization, 1970. Official Records of the 23rd World Health Assembly, No. 184. Geneva: World Health Organization.
  5. Roll Back Malaria Partnership, 2000. The African Summit on Roll Back Malaria. The Abuja Declaration and the Plan of Action. Accessed April 2, 2007. Available at: http://www.rbm.who.int/docs/abuja_declaration_final.htm.
  6. Roll Back Malaria Partnership, 1998. Roll Back Malaria: A Global Partnership. Geneva: Roll Back Malaria.
  7. The March of Dimes, 2007. Uniting to Beat Polio, 2007. Available at: http://www.marchofdimes.com/aboutus/789_821.asp. Accessed September 7, 2007.
  8. UNICEF, 2007. Past, Present and Future. Available at: http://www.unicef.org/about/who/index_introduction.html. Accessed September 7, 2007.
  9. AIDS Coalition to Unleash Power, 2007. ACT-UP: Capsule History. Available at: http://www.actupny.org/documents/capsule-home.html. Accessed September 7, 2007.
  10. The Global Fund to Fight AIDS, Tuberculosis and Malaria, 2007. The Global Fund to Fight AIDS, Tuberculosis, and Malaria: Pledges, 2001–2008. Available at: http://www.theglobalfund.org/en/files/pledges&contributions.xls. Accessed March 14, 2007.
  11. President’s Malaria Initiative, 2007. Saving Lives in Africa. Available at: http://www.fightingmalaria.gov/index.html. Accessed April 3, 2007.
  12. Sachs J, Malaney P, 2002. The economic and social burden of malaria. Nature 415 : 680–685.
    [Google Scholar]
  13. O’Brien S, Gibson I, Harris E, Drew D, Rea L, Kumar A, Laing E, Dykes S, 2007. All Party Parliamentary Malaria Group. Financing Mechanisms for Malaria. London, England: House of Commons.
  14. Malaney P, Spielman A, Sachs J, 2004. The malaria gap. Am J Trop Med Hyg 71 : 141–146.
    [Google Scholar]
  15. Malaria Vaccine Initiative, 2006. PATH Malaria Vaccine Initiative Announces New Partnership to Accelerate Development of Novel Malaria Vaccine Candidate. Available at: http://www.malariavaccine.org/. Accessed April 3, 2007.
  16. Roll Back Malaria Partnership, 2005. World Malaria Report 2005. Geneva: RBM Partnership, WHO, UNICEF, UNDP, and World Bank.
  17. Rational Pharmaceutical Management (RPM) Plus Program, 2005. Changing Malaria Treatment Policy to Artemisinin-Based Combinations: An Implementation Guide. Arlington, VA: Management Sciences for Health Rational Pharmaceutical Management (RPM) Plus Program, in collaboration with the Roll Back Malaria Partnership, Global Fund to Fight AIDS, Tuberculosis, and Malaria, and USAID.
  18. Taylor S, Berridge V, 2006. Medicinal plants and malaria: an historical case study of research at the London School of Hygiene and Tropical Medicine in the twentieth century. Trans R Soc Trop Med Hyg 100 : 707–714.
    [Google Scholar]
  19. Haynes RK, 2006. From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements. Curr Top Med Chem 6 : 509–537.
    [Google Scholar]
  20. Abdin MZ, Israr M, Rehman RU, Jain SK, 2003. Artemisinin, a novel antimalarial drug: biochemical and molecular approaches for enhanced production. Planta Med 69 : 289–299.
    [Google Scholar]
  21. Atemnkeng MA, De Cock K, Plaizier-Vercammen J, 2007. Post-marketing assessment of content and efficacy of preservatives in artemisinin-derived antimalarial dry suspensions for paediatric use. Malar J 6 : 12–18.
    [Google Scholar]
  22. Chanthap L, Tsuyuoka R, Na-Bangchang K, Nivanna N, Suksom D, Sovannarith T, Socheat D, 2005. Investigation of bioavailability, pharmacokinetics and safety of new pediatric formulations of artesunate and mefloquine. Southeast Asian J Trop Med Publ Health 36 : 34–43.
    [Google Scholar]
  23. Drugs for Neglected Diseases Initiative, 2005. Drugs for Neglected Diseases Initiative and Sanofi-Aventis to Deliver Artesunate Amodiaquine in 2006. Available at: http://www.dndi.org/cms/public_html/insidearticleListing.asp?categoryid=92&articleid=294&templateid=1. Accessed March 3, 2007.
  24. Coleman M, Sharp B, Seocharan I, Hemingway J, 2006. Developing an evidence-based decision support system for rational insecticide choice in the control of African malaria vectors. J Med Entomol 43 : 663–668.
    [Google Scholar]
  25. Mabaso ML, Sharp B, Lengeler C, 2004. Historical review of malarial control in southern African with emphasis on the use of indoor residual house-spraying. Trop Med Int Health 9 : 846–856.
    [Google Scholar]
  26. Sharp B, van Wyk P, Sikasote JB, Banda P, Kleinschmidt I, 2002. Malaria control by residual insecticide spraying in Chingola and Chililabombwe, Copperbelt Province, Zambia. Trop Med Int Health 7 : 732–736.
    [Google Scholar]
  27. Kleinschmidt I, Sharp B, Mueller I, Vounatsou P, 2002. Rise in malaria incidence rates in South Africa: a small-area spatial analysis of variation in time trends. Am J Epidemiol 155 : 257–264.
    [Google Scholar]
  28. Roll Back Malaria Partnership, 2005. Frequently Asked Questions (FAQs) on DDT Use for Disease Vector Control. Accessed April 2, 2007. Available at: http://www.who.int/malaria/docs/FAQonDDT.pdf.
  29. Multilateral Initiative on Malaria (MIM), 2007. About MIM. Available at: http://www.mimalaria.org/eng/aboutmim.asp. Accessed September 24, 2007.
  30. Roll Back Malaria Partnership, 2006. A Global Advocacy Framework to Roll Back Malaria 2006–2015. Accessed April 3, 2007. Available at: http://www.rollbackmalaria.org/globaladvocacy/docs/GlobalAdvocacyStrategy.pdf.
  31. Breman JG, Alilio MS, Mills A, 2004. Conquering the intolerable burden of malaria: what’s new, what’s needed: a summary. Am J Trop Med Hyg 71 (Suppl 2): 1–15.
    [Google Scholar]

Data & Media loading...

  • Received : 09 Apr 2007
  • Accepted : 03 Oct 2007

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error